All Pharma articles – Page 18
-
CommentThe biggest barrier to stopping HIV transmission is access to drugs
For those at greatest risk
-
SupplementsExcellent care supplement: Taking NHS standards to the next level
Effective management and evidence based care
-
SupplementsSupplement: Think on your feet for the best diabetes care
Give medicines optimisation a chance
-
-
-
Supplements
Value and Healthcare Awards: Value and Improvement in Clinical Support Services
Value in Healthcare Awards winners for 2015
-
Supplements
Value in Healthcare Awards: Value and Improvement in Medicines Management
Value in Healthcare Awards winners for 2015
-
Supplements
Value in Healthcare Awards: Workforce Efficiency
Value in Healthcare Awards winners for 2015
-
SupplementsValue in Healthcare Awards 2015
Learn about this year’s winning projects in HSJ’s celebration of organisations delivering real value
-
NewsRevealed: Winners of the Value in Healthcare Awards 2015
Chosen from a record breaking number of entries
-
CommentCuts in cancer spending expose a funding challenge
There will be tough choices over cash and cancer
-
NewsHigh profile treatments cut from cancer drugs fund
High profile cancer treatments including Roche’s Kadcyla and Avastin are to be removed from the cancer drugs fund.
-
CommentKelsey: Urgent action on a digital NHS is a moral imperative
The online revolution hasn’t reached the NHS
-
CommentDrugs access: Why the NHS is failing those with rare conditions
Access to treatment decision making
-
NewsDrug pricing deal change 'cuts NHS England's ability to provide care'
NHS England faces a ‘direct cut’ in its ability to provide care to patients as a result of a change to the deal that caps the price the government pays for branded medicines, a senior health economist has said.
-
NewsNHS staff to face new sanctions under ‘Sunshine rule’
NHS staff who fail to disclose payments and hospitality received from drug suppliers and medical device makers will be sanctioned under new regulation, health secretary Jeremy Hunt has said.
-
NewsBacklash expected over cancer drugs delisting
Talks are under way to identify high profile treatments to be removed from the cancer drugs fund in the coming months, HSJ has learned.
-
-
-
NewsCCG Barometer: explore the data
Findings from HSJ’s summer 2015 CCG barometer, carried out with Capsticks, which focus on commissioners’ approach to financial problems, and preferred solutions for unsustainable providers.